格隆汇3月7日丨业聚医疗(06929.HK)公布年度业绩,截至2024年12月31日止年度,集团收入为1.64亿美元,同比增长6.6%,此乃得益于美国市场的销售回升及亚太地区市场的持续增长。撇除汇兑影响,收入同比增幅为8.7%。于2024年,销量达1.7百万件,其中1.5百万件为自有产品,同比增加4.8%。毛利增加7.5%至约1.14亿美元,公司拥有人应占年内利润达3971.7万美元。亚太地区是...
Source Link格隆汇3月7日丨业聚医疗(06929.HK)公布年度业绩,截至2024年12月31日止年度,集团收入为1.64亿美元,同比增长6.6%,此乃得益于美国市场的销售回升及亚太地区市场的持续增长。撇除汇兑影响,收入同比增幅为8.7%。于2024年,销量达1.7百万件,其中1.5百万件为自有产品,同比增加4.8%。毛利增加7.5%至约1.14亿美元,公司拥有人应占年内利润达3971.7万美元。亚太地区是...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.